Therachem Research Medileb
Therachem Research Medileb offers end-to-end drug development services for pharmaceutical and biopharmaceutical partners. They execute discovery, development, and manufacturing using advanced chemistry and biology techniques. Core technologies include AI for preclinical candidate acceleration, flow chemistry, and biocatalysis, with capabilities in API and HPAPI manufacturing. As a CRDMO, they provide synthetic and medicinal chemistry, analytics, process development, and manufacturing across Europe and Asia. The company targets scale, cost efficiency, and sustainable solutions for drug development pipelines.
Therachem Research Medileb
Therachem Research Medileb offers end-to-end drug development services for pharmaceutical and biopharmaceutical partners. They execute discovery, development, and manufacturing using advanced chemistry and biology techniques. Core technologies include AI for preclinical candidate acceleration, flow chemistry, and biocatalysis, with capabilities in API and HPAPI manufacturing. As a CRDMO, they provide synthetic and medicinal chemistry, analytics, process development, and manufacturing across Europe and Asia. The company targets scale, cost efficiency, and sustainable solutions for drug development pipelines.